Richard Boateng
Overview
Explore the profile of Richard Boateng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boateng A, Boakye D, Botchwey C, Boateng R, Kumah E
J Nutr Metab
. 2025 Feb;
2025:4420685.
PMID: 39958368
Despite efforts to address malnutrition, it remains prevalent in Ghana and other developing nations. High rates of malnutrition hinder the achievement of the health-related sustainable development goals. Understanding the factors...
2.
Madorsky Rowdo F, Martini R, Ackermann S, Tang C, Tranquille M, Irizarry A, et al.
Cancer Res
. 2025 Feb;
85(3):551-566.
PMID: 39891928
Precision medicine approaches to cancer treatment aim to exploit genomic alterations that are specific to individual patients to tailor therapeutic strategies. Yet, some targetable genes and pathways are essential for...
3.
Frickmann H, Sarfo F, Norman B, Dompreh A, Asibey S, Boateng R, et al.
Pathogens
. 2025 Jan;
13(12.
PMID: 39770313
Although the etiological relevance of the detection of microsporidia in human stool samples remains uncertain, the immunological status of patients has been posited as an important determinant of potential clinical...
4.
Sarfo F, Frickmann H, Dompreh A, Asibey S, Boateng R, Weinreich F, et al.
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597540
There is a paucity of information on the prevalence, risk factors, and clinical correlates of people living with HIV (PLWH) who are co-infected with spp. in the post-combined antiretroviral therapy...
5.
Glyschewski L, Hahn A, Rohde H, Lutgehetmann M, Feldt T, Sarfo F, et al.
Eur J Microbiol Immunol (Bp)
. 2024 Oct;
14(4):346-360.
PMID: 39475752
Background: The study assessed replicative human immunodeficiency virus-(HIV-) infection and replicative co-infections as well as molecular determinants of reduced susceptibility towards anti-retroviral therapy in a Ghanaian population of known HIV...
6.
Ofoeda J, Boateng R, Effah J
Heliyon
. 2024 Jun;
10(11):e31756.
PMID: 38845900
Organisations deploy digital platforms to maximise value and transform their businesses. The success of most platforms is attributed to Application Programming Interfaces (APIs), the protocols enabling different software to communicate...
7.
Boateng S, Penu O, Boateng R, Budu J, Marfo J, Asamoah P
Heliyon
. 2024 Apr;
10(7):e28101.
PMID: 38601553
This bibliometric study critically analyses 293 journal articles from the Scopus database, charting the trajectory of educational technology in primary and elementary education from 1986 to 2023. While limited to...
8.
Buckman T, Sakyi S, Yeboah-Mensah K, Antwi M, Darban I, Owusu-Brenya L, et al.
Int J Rheumatol
. 2024 Jan;
2024:6639079.
PMID: 38249778
Background: Rheumatoid arthritis (RA) is one of the frequent chronic, systemic, inflammatory autoimmune disorders with an estimated global prevalence of 1%. RA leads to joint destruction and disability if left...
9.
Madorsky Rowdo F, Xiao G, Khramtsova G, Nguyen J, Martini R, Stonaker B, et al.
Cancer Lett
. 2024 Jan;
584:216608.
PMID: 38199587
Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with BRCA1/2 mutations, but patients with other mutations may benefit from PARPi treatment. Another mutation that is present in more cancers...
10.
Madorsky Rowdo F, Xiao G, Khramtsova G, Nguyen J, Olopade O, Martini R, et al.
bioRxiv
. 2023 Dec;
PMID: 38076873
Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with mutations, but patients with other mutations may benefit from PARPi treatment. Another mutation that is present in more cancers than...